Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Monserrat

Showing results (111-120 of 160) with videos related to

Pageof 16
Sort By:
European Heart Journal|September 9, 2010
Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseasesPhilippe Charron, Michael Arad, Eloisa Arbustini, et al.
International Journal of Cardiology|June 15, 2010
The R820W mutation in the MYBPC3 gene, associated with hypertrophic cardiomyopathy in cats, causes hypertrophic cardiomyopathy and left ventricular non-compaction in humansTomás Ripoll Vera, Lorenzo Monserrat Iglesias, Manuel Hermida Prieto, et al.
Revista Espanola De Cardiologia (English Ed.)|April 26, 2018
Digenic Heterozigosity in SCN5A and CACNA1C Explains the Variable Expressivity of the Long QT Phenotype in a Spanish FamilyPaloma Nieto-Marín, Juan Jiménez-Jáimez, David Tinaquero, et al.
Journal of Cellular and Molecular Medicine|January 9, 2019
Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patientsBinyamin Eisen, Ronen Ben Jehuda, Ashley J Cuttitta, et al.
Medicina Clinica|August 23, 2020
Clinical utility of genetic testing in patients with dilated cardiomyopathyMaria Luisa Peña-Peña, Juan Pablo Ochoa, Roberto Barriales-Villa, et al.
International Journal of Cardiology|May 7, 2020
Prognostic implications of pathogenic truncating variants in the TTN geneMaria Luisa Peña-Peña, Juan Pablo Ochoa, Roberto Barriales-Villa, et al.
Clinical Genetics|April 27, 2020
Deletions of specific exons of FHOD3 detected by next-generation sequencing are associated with hypertrophic cardiomyopathyJuan P Ochoa, Luis R Lopes, Marlene Perez-Barbeito, et al.
Journal of the American College of Cardiology|April 14, 2018
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT SyndromeAndrea Mazzanti, Riccardo Maragna, Gaetano Vacanti, et al.
The American Journal of Cardiology|July 21, 2015
Diagnostic Approach to Unexplained Cardiac Arrest (from the FIVI-Gen Study)Juan Jiménez-Jáimez, Rafael Peinado, Esther Zorio Grima, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 23, 2016
Genetic basis of familial dilated cardiomyopathy patients undergoing heart transplantationSofia Cuenca, Maria J Ruiz-Cano, Juan Ramón Gimeno-Blanes, et al.
Pageof 16

Showing results (111-120 of 160) with videos related to

Sort By:
Pageof 16
European Heart Journal|September 9, 2010
Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseasesPhilippe Charron, Michael Arad, Eloisa Arbustini, et al.
International Journal of Cardiology|June 15, 2010
The R820W mutation in the MYBPC3 gene, associated with hypertrophic cardiomyopathy in cats, causes hypertrophic cardiomyopathy and left ventricular non-compaction in humansTomás Ripoll Vera, Lorenzo Monserrat Iglesias, Manuel Hermida Prieto, et al.
Revista Espanola De Cardiologia (English Ed.)|April 26, 2018
Digenic Heterozigosity in SCN5A and CACNA1C Explains the Variable Expressivity of the Long QT Phenotype in a Spanish FamilyPaloma Nieto-Marín, Juan Jiménez-Jáimez, David Tinaquero, et al.
Journal of Cellular and Molecular Medicine|January 9, 2019
Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patientsBinyamin Eisen, Ronen Ben Jehuda, Ashley J Cuttitta, et al.
Medicina Clinica|August 23, 2020
Clinical utility of genetic testing in patients with dilated cardiomyopathyMaria Luisa Peña-Peña, Juan Pablo Ochoa, Roberto Barriales-Villa, et al.
International Journal of Cardiology|May 7, 2020
Prognostic implications of pathogenic truncating variants in the TTN geneMaria Luisa Peña-Peña, Juan Pablo Ochoa, Roberto Barriales-Villa, et al.
Clinical Genetics|April 27, 2020
Deletions of specific exons of FHOD3 detected by next-generation sequencing are associated with hypertrophic cardiomyopathyJuan P Ochoa, Luis R Lopes, Marlene Perez-Barbeito, et al.
Journal of the American College of Cardiology|April 14, 2018
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT SyndromeAndrea Mazzanti, Riccardo Maragna, Gaetano Vacanti, et al.
The American Journal of Cardiology|July 21, 2015
Diagnostic Approach to Unexplained Cardiac Arrest (from the FIVI-Gen Study)Juan Jiménez-Jáimez, Rafael Peinado, Esther Zorio Grima, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 23, 2016
Genetic basis of familial dilated cardiomyopathy patients undergoing heart transplantationSofia Cuenca, Maria J Ruiz-Cano, Juan Ramón Gimeno-Blanes, et al.
Pageof 16